Cooke Julie sold $661K of NBIX
Cooke Julie (Chief Human Resources Officer) sold 4,216 shares of NEUROCRINE BIOSCIENCES INC (NBIX) at $156.77 ($0.66M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides a datapoint on insider activity, but the pre-arranged 10b5-1 structure typically limits interpretive value for near-term price direction.
Market read
Insider selling disclosure for NBIX; likely sentiment-neutral unless paired with other catalysts.
What to watch
Traders may over-weight insider selling; the key is whether there is concurrent news (trial/regulatory/earnings) that would change fundamentals.
Background
The article is an SEC Form 4 insider transaction filing (officer/direct holding) for Neurocrine Biosciences.
Ticker impact
Neurocrine Biosciences insider disclosure shows HR officer Julie Cooke sold 4,216 shares in an open-market transaction under a 10b5-1 plan.
Low near-term impact; any reaction likely fades unless accompanied by other company-specific news.
Form 4 insider sales are common and the filing explicitly notes a pre-arranged 10b5-1 plan, reducing signal strength versus discretionary selling.
Market effects
Minimal; single-company insider sale without accompanying operational/regulatory/drug-trial updates.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.
Key entities
- issuerNeurocrine Biosciences, Inc.
NBIX insider transaction: HR officer Julie Cooke sold 4,216 shares at $156.7660 on 2026-06-02.
- insiderJulie Cooke
Chief Human Resources Officer; sold shares directly under a Rule 10b5-1 plan.
